- Home
- BOWN vs DYAI Comparison
BOWN vs DYAI Comparison
Compare BOWN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOWN
- DYAI
- Stock Information
- Founded
- BOWN 2023
- DYAI 1979
- Country
- BOWN United States
- DYAI United States
- Employees
- BOWN N/A
- DYAI N/A
- Industry
- BOWN
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BOWN
- DYAI Health Care
- Exchange
- BOWN Nasdaq
- DYAI Nasdaq
- Market Cap
- BOWN 28.5M
- DYAI 28.3M
- IPO Year
- BOWN 2023
- DYAI 2004
- Fundamental
- Price
- BOWN N/A
- DYAI $0.98
- Analyst Decision
- BOWN
- DYAI Strong Buy
- Analyst Count
- BOWN 0
- DYAI 1
- Target Price
- BOWN N/A
- DYAI $6.00
- AVG Volume (30 Days)
- BOWN 2.6K
- DYAI 63.9K
- Earning Date
- BOWN 01-01-0001
- DYAI 08-12-2025
- Dividend Yield
- BOWN N/A
- DYAI N/A
- EPS Growth
- BOWN N/A
- DYAI N/A
- EPS
- BOWN 0.02
- DYAI N/A
- Revenue
- BOWN N/A
- DYAI $3,554,344.00
- Revenue This Year
- BOWN N/A
- DYAI $22.56
- Revenue Next Year
- BOWN N/A
- DYAI $30.95
- P/E Ratio
- BOWN $206.51
- DYAI N/A
- Revenue Growth
- BOWN N/A
- DYAI 57.59
- 52 Week Low
- BOWN $2.71
- DYAI $0.91
- 52 Week High
- BOWN $19.77
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- BOWN 49.69
- DYAI 53.08
- Support Level
- BOWN $8.70
- DYAI $0.91
- Resistance Level
- BOWN $10.20
- DYAI $0.99
- Average True Range (ATR)
- BOWN 0.42
- DYAI 0.06
- MACD
- BOWN 0.04
- DYAI 0.01
- Stochastic Oscillator
- BOWN 79.04
- DYAI 59.93
About BOWN Bowen Acquisition Corp
Bowen Acquisition Corp is a blank check company.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.